Biolex Therapeutics' Series D - II Round

Biolex Therapeutics raised a round of funding on October 07, 2010.

Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been op…

Articles about Biolex Therapeutics' Series D - II Round: